Freedom Broker still thinks Niagen Bioscience is a good buy but cut its price target from $8.50 to $6.

Nov 7, 2026, 9:57 AM ETOpinionRead the original at tradingview.com

Neutral

Freedom Broker cut its price target 29.4% to $6, but kept its Buy rating and said the target was 189.9% above the closing price. Those mixed broker views do not change Niagen Bioscience's outlook.

NAGE · Niagen Bioscience

AI read · Neutral

The AI's read

The lower target points to a weaker view than before. Keeping the Buy rating and a target 189.9% above the closing price points the other way. These mixed opinions from one broker are not new company results, so they do not change the company's outlook.

Get alerts for NAGE

Follow Niagen Bioscience (NAGE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NAGE

Free on the App Store and Google Play, or on the web.